Bioluminescence is a powerful, inexpensive, and non-invasive method to monitor gene expression, enzymatic activity, protein-protein interactions and response to therapeutics both in vitro and in vivo. However, bioluminescence requires the use of a luciferase derived from a small number of luminogenic organisms (e.g., fireflies), and is limited to applications and organisms where genetic manipulation is both possible and practical. In this exploratory/developmental grant, we will identify proteins in non-luminous species that are latent luciferases, capable of bioluminescent light emission when treated with an appropriate substrate. In support of this substrate-directed approach, we have identified a fruit fly protein that is revealed to be a luciferase when treated with a synthetic luciferin analog. This unprecedented result shows that the function of a protein can be fundamentally changed simply by modification of the substrate, rather than by mutation. Beyond the paradigm-shifting implications for the evolution and design of new enzymatic activities, the prospect that non-luminogenic organisms encode latent luciferases has transformative potential for the non-invasive optical imaging of endogenous processes, potentially enabling bioluminescence imaging in native cells and organisms without the need for the introduction of an exogenous luciferase.

Public Health Relevance

Bioluminescence is a powerful, inexpensive, and non-invasive method to monitor gene expression, enzymatic activity, protein-protein interactions and response to therapeutics both in vitro and in vivo. However, this technique requires the use of a luciferase derived from a small number of bioluminescent organisms (e.g., fireflies), and is limited to applications and organisms where genetic manipulation is both possible and practical. In this exploratory/developmental grant, we will identify proteins that can enable bioluminescence imaging in native cells and organisms without the need for the introduction of an exogenous luciferase.

Agency
National Institute of Health (NIH)
Institute
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21EB020243-01A1
Application #
9035326
Study Section
Special Emphasis Panel (ZRG1-EBIT-R (09))
Program Officer
Peterson, Karen P
Project Start
2015-12-15
Project End
2017-11-30
Budget Start
2015-12-15
Budget End
2016-11-30
Support Year
1
Fiscal Year
2016
Total Cost
$251,250
Indirect Cost
$101,250
Name
University of Massachusetts Medical School Worcester
Department
Biochemistry
Type
Schools of Medicine
DUNS #
603847393
City
Worcester
State
MA
Country
United States
Zip Code
01655
Miller, Stephen C; Mofford, David M; Adams Jr, Spencer T (2018) Lessons Learned from Luminous Luciferins and Latent Luciferases. ACS Chem Biol 13:1734-1740
Sharma, Deepak K; Adams Jr, Spencer T; Liebmann, Kate L et al. (2017) Rapid Access to a Broad Range of 6'-Substituted Firefly Luciferin Analogues Reveals Surprising Emitters and Inhibitors. Org Lett 19:5836-5839
Mofford, David M; Liebmann, Kate L; Sankaran, Ganapathy Subramanian et al. (2017) Luciferase Activity of Insect Fatty Acyl-CoA Synthetases with Synthetic Luciferins. ACS Chem Biol 12:2946-2951